Jens Overgaard

Jens Overgaard's AcademicInfluence.com Rankings

Jens Overgaard

Biology

#3029

World Rank

#4693

Historical Rank

Ecology

#98

World Rank

#113

Historical Rank

biology Degrees

Download Badge

Biology

Jens Overgaard's Degrees

PhD Biology Aarhus University
Masters Biology Aarhus University
Bachelors Biology Aarhus University

Similar Degrees You Can Earn

Why Is Jens Overgaard Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jens Overgaard's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. (1997) (2459)
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial (1999) (1459)
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. (1996) (1007)
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis (2006) (1005)
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. (2005) (899)
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. (2009) (626)
Hypoxic radiosensitization: adored and ignored. (2007) (570)
Radiation oncology in the era of precision medicine (2016) (553)
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial (2003) (546)
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. (2008) (534)
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma (1995) (526)
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. (1998) (519)
Imaging hypoxia to improve radiotherapy outcome (2012) (493)
The current and potential role of hyperthermia in radiotherapy. (1989) (486)
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. (2007) (433)
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis. (2011) (411)
Hyperthermia: a potent enhancer of radiotherapy. (2007) (411)
Effect of hyperthermia on malignant cells in vivo: A review and a hypothesis (1977) (361)
Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. (1980) (347)
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. (2016) (322)
Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. (2006) (322)
Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials (1999) (314)
Investigations on the possibility of a thermic tumour therapy. I. Short-wave treatment of a transplanted isologous mouse mammary carcinoma. (1972) (312)
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group. (2005) (310)
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. (2012) (296)
A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. (2000) (294)
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). (2009) (287)
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. (2005) (283)
Radiotherapy-related lung fibrosis enhanced by tamoxifen. (1996) (267)
Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. (1988) (255)
Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study (1986) (255)
Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival. (1986) (249)
Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. (1998) (237)
Tumor progression in waiting time for radiotherapy in head and neck cancer. (2007) (235)
Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. (1994) (228)
Clinical radiobiology of malignant melanoma. (1989) (226)
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers (2010) (224)
Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations (2001) (224)
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. (2003) (223)
Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. (1989) (218)
The impact of hypoxia and its modification of the outcome of radiotherapy (2016) (216)
Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. (2009) (207)
Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer. (2011) (206)
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. (2012) (200)
Quality assurance in radiotherapy. European Society for Therapeutic Radiology and Oncology Advisory Report to the Commission of the European Union for the 'Europe Against Cancer Programme'. (1995) (194)
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. (2017) (194)
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. (2010) (193)
Does variability in normal tissue reactions after radiotherapy have a genetic basis--where and how to look for it? (2002) (192)
The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. (2011) (184)
Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. (1994) (182)
Clinical radiobiology of squamous cell carcinoma of the oropharynx. (1991) (176)
Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). (2011) (165)
Sensitization of hypoxic tumour cells--clinical experience. (1989) (164)
Risk of second primary lung cancer in women after radiotherapy for breast cancer. (2014) (163)
Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. (1996) (163)
Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. (1997) (159)
Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. (2015) (158)
The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro. (1977) (156)
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. (1999) (155)
Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. (2003) (155)
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. (2014) (154)
The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. (1986) (149)
Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). (2013) (147)
Some factors of importance in the radiation treatment of malignant melanoma. (1986) (146)
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. (2002) (144)
Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia. (1976) (144)
The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. (1996) (144)
A future for hyperthermia in cancer treatment? (2001) (143)
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. (2005) (143)
Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients. (1997) (142)
Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study (2008) (142)
Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting. (2000) (138)
Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer (2004) (137)
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology (2009) (136)
Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. (2006) (135)
Impact of Delay on Diagnosis and Treatment of Primary Lung Cancer (2002) (134)
Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer. (1984) (133)
Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. (1994) (132)
Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. (1989) (130)
Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer (2009) (129)
In vitro RBE-LET dependence for multiple particle types (2011) (128)
Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. (1994) (126)
Time-temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo. (1979) (125)
Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. (2003) (124)
Radiation treatment of malignant melanoma. (1980) (122)
High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. (2009) (121)
Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study (2014) (120)
Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. (2006) (118)
Long-Term Anorectal Dysfunction After Postoperative Radiotherapy for Rectal Cancer (2005) (117)
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. (2004) (117)
Influence of oxygen concentration and pH on expression of hypoxia induced genes. (2005) (116)
Fractionated radiation and hyperthermia: Experimental and clinical studies (1981) (115)
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage (2008) (115)
Aerobic glycolysis in cancers: Implications for the usability of oxygen‐responsive genes and fluorodeoxyglucose‐PET as markers of tissue hypoxia (2008) (114)
Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. (2010) (114)
Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors. (2001) (114)
National Institutes of Health Consensus Development Conference Statement on Cervical Cancer (1997) (114)
Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. (1991) (113)
Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study. (2012) (112)
Genetic markers for prediction of normal tissue toxicity after radiotherapy. (2008) (111)
LET-painting increases tumour control probability in hypoxic tumours (2014) (111)
THE ROLE OF TISSUE ENVIRONMENTAL FACTORS ON THE KINETICS AND MORPHOLOGY OF TUMOR CELLS EXPOSED TO HYPERTHERMIA * (1980) (111)
Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATMndash; a study based on DNA from formalin fixed paraffin embedded tissue samples (2006) (109)
Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo. (1976) (109)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group. (2016) (109)
Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c (2014) (108)
Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells. (1990) (108)
The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study. (2006) (107)
Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia (2019) (107)
Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma. (1987) (107)
TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. (2001) (107)
Treatment Morbidity Associated with the Management of the Axilla in Breast-Conserving Therapy (2000) (107)
Familial cancer associated with a polymorphism in ARLTS1. (2005) (107)
Investigation on the possibility of a thermic tumour therapy. II. Action of combined heat-roentgen treatment on a transplanted mouse mammary carcinoma. (1972) (107)
Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment Alone (2000) (106)
Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. (1993) (105)
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG (2016) (105)
Hyperfractionated or accelerated radiotherapy for head and neck cancer. (2010) (104)
Early and late treatment‐related morbidity following radical cystectomy (2004) (104)
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium (2015) (104)
The importance of thermotolerance for the clinical treatment with hyperthermia. (1983) (103)
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. (2009) (102)
Malignant parotid tumors in 110 consecutive patients: Treatment results and prognosis (1992) (102)
Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. (1992) (101)
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer. (1998) (101)
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial. (2020) (101)
Pharyngo‐cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole (1988) (101)
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2016) (100)
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer (2011) (99)
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: A national survey from DAHANCA (2003) (99)
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. (2001) (99)
ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. (2006) (98)
Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark (2002) (98)
Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project. (2017) (98)
Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells. (2013) (97)
The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. (2005) (96)
Cosmetic Outcome and Breast Morbidity in Breast-Conserving Treatment (2002) (95)
Effect of extracellular pH on thermotolerance and recovery of hyperthermic damage in vitro. (1979) (95)
The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors. (1998) (95)
Late effects consensus conference: RTOG/EORTC. (1995) (94)
Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. (2014) (93)
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients (2008) (93)
A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma. (1985) (93)
Ultrastructure of a murine mammary carcinoma exposed to hyperthermia in vivo. (1976) (92)
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. (2016) (92)
Shoulder disability and late symptoms following surgery for early breast cancer (2008) (91)
Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. (2002) (90)
Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. (1991) (90)
Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. (1988) (90)
Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy. (2008) (90)
Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. (1999) (89)
Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. (2003) (89)
The impact of comorbidity on outcome in 12 623 Danish Head and Neck Cancer Patients: A population based study from the DAHANCA database (2013) (89)
Patterns of angiogenesis in nonsmall‐cell lung carcinoma (2001) (87)
Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts. (2005) (87)
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. (2007) (87)
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. (1993) (87)
Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial. (2013) (86)
Hypopharyngeal squamous cell carcinoma--treatment results in 138 consecutively admitted patients. (2000) (86)
Evaluation of Objective Measures of Smoking Status A Prospective Clinical Study in a Group of Head and Neck Cancer Patients Treated with Radiotherapy (2003) (86)
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer. (2012) (85)
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome (2017) (85)
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode (2010) (85)
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors (2013) (85)
TP53 Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast Cancer (2000) (85)
Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo. (1982) (84)
Does amifostine have a role in chemoradiation treatment? (2003) (83)
Improved Tumor Response by Combining Radiation and the Vascular-Damaging Drug 5,6-Dimethylxanthenone-4-acetic Acid (2001) (83)
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients (2000) (82)
Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. (2008) (82)
Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. (1994) (81)
Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! (1995) (81)
Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. (1986) (81)
Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. (2008) (80)
Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. (1989) (80)
Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes (2004) (79)
Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model. (1993) (79)
Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort (2014) (78)
Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients. (2016) (78)
Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin. (1981) (78)
Mechanism of action of the selective tumor radiosensitizer nicotinamide. (1988) (77)
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. (2003) (77)
Uveal and Conjunctival Malignant Melanoma in Denmark, 1943–97: Incidence and Validation Study (2005) (77)
Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing. (1992) (75)
Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. (1990) (75)
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study (2015) (75)
Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients. (2000) (74)
Hot Topic: Can mild hyperthermia improve tumour oxygenation? (1997) (73)
CT-planned internal mammary node radiotherapy in the DBCG-IMN study: Benefit versus potentially harmful effects (2014) (72)
Resolution in PET hypoxia imaging: Voxel size matters (2008) (72)
Long-term colorectal function after postoperative radiotherapy for colorectal cancer (1997) (71)
Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmastectomy radiotherapy. (1988) (71)
110Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week — Preliminary report from the Dahanca 6 and 7 trial (1996) (70)
Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. (2012) (70)
Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA). (2012) (70)
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro (2010) (70)
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. (1994) (69)
Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH. (2007) (68)
Significance of Hemoglobin Concentration for Treatment Outcome (2000) (68)
Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues. (2001) (67)
Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance. (2013) (67)
Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. (1998) (66)
The oxygen effect and fractionated radiotherapy (2009) (66)
Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy. (2001) (66)
Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. (2007) (65)
The natural history of prostate carcinoma based on a Danish population treated with no intent to cure (1997) (64)
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo. (1982) (64)
Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation (2014) (64)
Diagnostic intervals before and after implementation of cancer patient pathways – a GP survey and registry based comparison of three cohorts of cancer patients (2015) (64)
Arrhenius analysis of survival curves from thermotolerant and step-down heated L1A2 cells in vitro. (1982) (64)
Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. (2013) (63)
Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. (1998) (63)
A Hyperthermia System Using a New Type of Inductive Applicator (1984) (63)
Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. (2003) (63)
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins (2013) (63)
Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis. (2010) (62)
Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. (1999) (62)
Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? (2009) (61)
Uveal and Conjunctival Malignant Melanoma in Denmark 1943–97: Observed and Relative Survival of Patients Followed Through 2002 (2006) (61)
Assessment of Hypoxia in Experimental Mice Tumours by [ 18 F] Fluoromisonidazole PET and pO 2 Electrode Measurements (2002) (61)
Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. (1989) (61)
The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study. (2011) (60)
Tumor cell proliferation and survival in patients with prostate cancer followed expectantly. (1998) (59)
Postirradiation sensorineural hearing loss: a common but ignored late radiation complication. (1996) (59)
A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis? (1988) (59)
The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo. (1990) (59)
Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study (2009) (59)
Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. (1980) (59)
Feasibility and efficacy of progressive resistance training and dietary supplements in radiotherapy treated head and neck cancer patients – the DAHANCA 25A study (2013) (58)
Stereologic, histopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas (1992) (56)
Dependence of cell survival on instantaneous dose rate of a linear accelerator. (2011) (56)
Prognostic indicators for malignant tumours of the parotid gland. (2002) (56)
Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials. (2013) (55)
Squamous cell carcinoma of the oropharynx--an analysis of treatment results in 289 consecutive patients. (2000) (55)
Importance of preheating temperature and time for the induction of thermotolerance in a solid tumour in vivo. (1982) (55)
PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice (2012) (54)
Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo (2017) (54)
Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. (1995) (54)
Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. (2011) (54)
Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG) (2013) (53)
Expression of integrins and E‐cadherin in squamous cell carcinomas of the head and neck (2004) (53)
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. (2007) (53)
p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting. (2000) (52)
Germline Mutation in RNASEL Predicts Increased Risk of Head and Neck, Uterine Cervix and Breast Cancer (2008) (52)
Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma? (1990) (52)
Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. (2004) (52)
Lean body mass and muscle function in head and neck cancer patients and healthy individuals – results from the DAHANCA 25 study (2013) (52)
Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials (2016) (51)
Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis (2002) (50)
Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure. (1992) (50)
Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction. (2013) (50)
Long-term evaluation of postmastectomy breast reconstruction (2011) (49)
Socioeconomic position and stage at diagnosis of head and neck cancer – a nationwide study from DAHANCA (2015) (49)
Blood transfusion and prognosis in Dukes' B and C colorectal cancer. (1990) (49)
Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. (2004) (49)
About tolerance and quality. An important notice to all radiation oncologists. (1995) (48)
The heat is (still) on--the past and future of hyperthermic radiation oncology. (2013) (48)
Influence of time and temperature on the kinetics of thermotolerance in L1A2 cells in vitro. (1982) (48)
Radiotherapy and Oncology comes of age. (2005) (48)
Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. (2002) (47)
Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis. (2007) (47)
Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapy. (2000) (46)
Laryngeal Carcinoma Multivariate Analysis of Prognostic Factors in 1 252 Consecutive Patients Treated with Primary Radiotherapy (2003) (46)
Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status. (1989) (46)
Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation (2007) (46)
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival (2010) (46)
Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model. (1992) (46)
Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer (1998) (45)
Papillary thyroid carcinoma in Denmark, 1996-2008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort. (2015) (45)
Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing. (1997) (45)
Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: A Danish nationwide survey from DAHANCA (2006) (45)
The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. (2015) (45)
Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study. (2011) (44)
Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials (2011) (44)
Integrating Proteomic and Functional Genomic Technologies in Discovery-driven Translational Breast Cancer Research* (2003) (44)
Influence of thermotolerance on the interaction between hyperthermia and radiation in a solid tumour in vivo. (1983) (44)
SNP in TXNRD2 associated with radiation-induced fibrosis: a study of genetic variation in reactive oxygen species metabolism and signaling. (2013) (43)
Can mild hyperthermia improve tumour oxygenation? (1997) (43)
Combretastatins Novel Vascular targeting Drugs for Improving Anticancer therapy (2000) (43)
Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation. (2001) (43)
Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts (1999) (43)
A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma. (1993) (42)
Papillary thyroid carcinoma in Denmark 1996-2008: an investigation of changes in incidence. (2013) (42)
The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation. (1995) (42)
Effect of hyperthermia on the hypoxic fraction in an experimental mammary carcinoma in vivo. (1981) (42)
Multifractionated hyperthermia treatment of malignant and normal tissue in vivo. (1980) (42)
Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck. (1999) (41)
Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET (2010) (41)
Influence of sequence and interval on the biological response to combined hyperthermia and radiation. (1982) (41)
Time course of radiological lung density changes after postmastectomy radiotherapy. (2000) (41)
Squamous cell carcinoma of the oropharynx: An analysis of 213 consecutive patients scheduled for primary radiotherapy (1990) (41)
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer (2013) (41)
106 Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-report from the Dahanca 7 trial (1997) (40)
Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics. (2009) (40)
Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient data (2002) (40)
Cystometric evaluation of early and late irradiation damage to the mouse urinary bladder. (1989) (40)
The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen‐receptor positive tumors (2014) (39)
For X-irradiated normal human fibroblasts, only half of cell inactivation results from chromosomal damage. (2004) (39)
Quantitative PCR – new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real‐time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization (2004) (39)
Factors of importance for the development of the step-down heating effect in a C3H mammary carcinoma in vivo. (1987) (39)
Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients (2003) (39)
Image-guided adaptive radiotherapy – integration of biology and technology to improve clinical outcome (2008) (39)
Prognostic Factors, Pattern of Recurrence and Survival in a Danish Bladder Cancer Cohort Treated with Radical Cystectomy (2003) (38)
Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial. (2009) (38)
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing. (2002) (37)
Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. (2000) (37)
Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases. (2013) (37)
Primary leiomyosarcoma of bone (1977) (37)
A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas (2008) (36)
The Danish Head and Neck Cancer database (2016) (36)
Radiation sensitizing effect of heat. (1974) (36)
Comparison of methods of microvascular staining and quantification in prostate carcinoma: Relevance to prognosis (2002) (36)
Studies of the pharmacokinetic properties of nimorazole. (1983) (35)
Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group. (2016) (35)
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group. (2018) (35)
Effect of carboxyhemoglobin on tumor oxygen unloading capacity in patients with squamous cell carcinoma of the head and neck. (1992) (35)
Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer (2014) (35)
The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times. (2005) (35)
Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment. (2011) (35)
Allelic imbalance in selected chromosomal regions in ovarian cancer. (2002) (35)
Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay. (1997) (35)
Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system. (1993) (34)
The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma. (1990) (33)
Validity and Representativity in the Danish Breast Cancer Cooperative Group (2003) (33)
Abstract GS4-02: Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials (2019) (33)
IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. (2015) (33)
Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck. (1998) (33)
Failure pattern and salvage treatment after radical treatment of head and neck cancer (2016) (33)
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose. (2000) (33)
The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA (2013) (32)
Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model. (1995) (32)
A phase I clinical study of Nimorazole as a hypoxic radiosensitizer. (1984) (32)
Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo. (1991) (32)
The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. (2020) (32)
Hyperthermia as an adjuvant to radiotherapy. Review of the randomized multicenter studies of the European Society for Hyperthermic Oncology. (1987) (32)
The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma (2005) (32)
Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice. (1992) (32)
The use of blood flow modifiers to improve the treatment response of solid tumors. (1991) (32)
Overcoming tumour radiation resistance resulting from acute hypoxia. (1992) (31)
Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model (2015) (31)
Hyperthermic radiosensitization of thermotolerant tumour cells in vitro. (1979) (31)
Hyperthermic effect on exponential and plateau ascites tumor cells in vitro dependent on environmental pH1. (1977) (31)
Tumour oxygenation assessed by polarographic needle electrodes and bioenergetic status measured by 31P magnetic resonance spectroscopy in human soft tissue tumours. (1997) (31)
Impact of age on treatment effect in locally advanced head and neck cancer (HNC): Two individual patient data meta-analyses. (2006) (31)
Biological Basis for Rational Design of Clinical Treatment with Combined Hyperthermia and Radiation (1987) (31)
The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study (2015) (31)
The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types. (2015) (31)
Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins. (2017) (31)
Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy. (2001) (30)
The influence of haemoglobin concentration on the response to radiotherapy (1988) (29)
Importance of margin width in breast‐conserving treatment of early breast cancer (2016) (29)
Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material. (2004) (29)
Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study (2013) (29)
The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. (2003) (29)
A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer (2008) (28)
Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark. (2003) (28)
A community call for a dedicated radiobiological research facility to support particle beam cancer therapy. (2012) (28)
Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy. (2005) (28)
In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome (2010) (28)
Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC) (2014) (28)
Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo. (1994) (28)
Affiliation to the work market after curative treatment of head-and-neck cancer: A population-based study from the DAHANCA database (2013) (27)
Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay. (1995) (27)
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions. (2020) (27)
The prognostic relevance of estimates of proliferative activity in early breast cancer (2003) (27)
The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategies. (1997) (27)
Evidence based radiation oncology. (1998) (27)
Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden? (2004) (27)
Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C (1982) (27)
Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid. (2001) (27)
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor. (2005) (27)
Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy. (2020) (26)
Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays. (1998) (26)
Some problems related to the clinical use of thermal isoeffect doses. (1987) (26)
Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo. (1990) (25)
Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours. (1995) (25)
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ (2004) (25)
The European core curriculum on radiotherapy. (1991) (25)
Completeness and validity in a national clinical thyroid cancer database: DATHYRCA. (2014) (25)
Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression. (2012) (25)
Optimal Reference Genes for Normalization of qRT-PCR Data from Archival Formalin-fixed, Paraffin-embedded Breast Tumors Controlling for Tumor Cell Content and Decay of mRNA (2013) (25)
The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo. (1994) (25)
Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model (2013) (24)
Effect of radiation on glucose absorption in the mouse jejunum in vivo. (1990) (24)
Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987. (1991) (24)
Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial (2015) (24)
The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models (2008) (24)
The in vivo interaction between flavone acetic acid and hyperthermia. (1996) (23)
Interactions of radiation and cancer chemotherapeutic drugs in a C3H mouse mammary carcinoma. (1985) (23)
Independent prospective validation of a predictive test for risk of radiation induced fibrosis based on the gene expression pattern in fibroblasts irradiated in vitro. (2013) (23)
Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis (2014) (23)
Growth of vestibular schwannomas: in situ model employing the monoclonal antibody Ki-67 and DNA flow cytometry. (1996) (23)
The potential of using hyperthermia to eliminate radioresistant hypoxic cells. (1991) (23)
PET imaging of tumor hypoxia using 18F-labeled pimonidazole (2013) (23)
Trends in breast cancer during three decades in Denmark: Stage at diagnosis, surgical management and survival (2008) (23)
Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo. (1981) (22)
In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data (1999) (22)
Biology-guided adaptive radiotherapy (BiGART) – more than a vision? (2013) (22)
Quantitative magnetic resonance for assessment of radiation fibrosis after post-mastectomy radiotherapy. (1994) (22)
Identification of Thermal Model for Human Tissue (1986) (22)
Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma. (2003) (22)
Effect of hyperthermia and environmental acidity on the proteolytic activity in murine ascites tumor cells. (1977) (22)
Effect of step-down heating on hyperthermic radiosensitization in an experimental tumor and a normal tissue in vivo. (1988) (22)
Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events (2011) (22)
External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort (2015) (21)
Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma (2006) (21)
TREATMENT OF EARLY CARCINOMA OF THE BREAST (1979) (21)
No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls. (2011) (21)
Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature. (1992) (21)
Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder. (1992) (21)
Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients (2017) (21)
Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance. (2019) (20)
Hyperthermia in clinical oncology. (1990) (20)
LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer (2006) (20)
Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions. (1997) (20)
Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials (2008) (20)
Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck. (2001) (20)
Techniques to assess the oxygenation of human tumors. State of the art. (1998) (20)
Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2. (2004) (20)
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy – results from two independent randomized trials (2018) (19)
The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model. (1997) (19)
Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy. (2019) (19)
Evaluation of the EGFR-Inhibitor Zalutumumab Given With Primary Curative (Chemo)radiation Therapy to Patients With Squamous Cell Carcinoma of the Head and Neck: Results of the DAHANCA 19 Randomized Phase 3 Trial (2014) (19)
The emerging evidence for Stereotactic Body Radiotherapy (2006) (19)
Is there a radiobiologic basis for improving the treatment of advanced stage cervical cancer? (1996) (19)
Hyperthermic tumour-cell devitalization in vivo. (1977) (19)
Differential gene expression in primary fibroblasts induced by proton and cobalt-60 beam irradiation (2017) (19)
Chalkley Estimates of Angiogenesis in Early Breast Cancer - Relevance to Prognosis (2002) (19)
THE EFFECT OF PHOTODYNAMIC THERAPY ALONE AND IN COMBINATION WITH MISONIDAZOLE OR X‐RAYS FOR MANAGEMENT OF A RETINOBLASTOMA‐LIKE TUMOUR † (1988) (19)
Formula to estimate the thermal enhancement ratio of a single simultaneous hyperthermia and radiation treatment. (1984) (19)
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. (2021) (19)
A longitudinal study of follow-up activities after curative treatment for head and neck cancer (2015) (19)
Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash (2017) (18)
The effect of shark cartilage extracts on the growth and metastatic spread of the SCCVII carcinoma. (1998) (18)
Orgotein in radiation treatment of bladder cancer. A report on allergic reactions and lack of radioprotective effect. (1987) (18)
Auditory brain stem responses in patients after radiation therapy for nasopharyngeal carcinoma (1992) (18)
Isotherm mapping in hyperthermia using subtraction X-ray computed tomography. (1984) (18)
Repopulation in the SCCVII squamous cell carcinoma assessed by an in vivo-in vitro excision assay. (1996) (18)
An evaluation of multiplex bead-based analysis of cytokines and soluble proteins in archived lithium heparin plasma, EDTA plasma and serum samples (2016) (18)
Biology-guided adaptive radiation therapy – presence or future? (2010) (18)
Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c (2008) (18)
Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response (2006) (18)
Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods (2017) (18)
Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group (2008) (17)
NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy (2019) (17)
Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients. (2016) (17)
Simultaneous Hypoxia and Low Extracellular pH Suppress Overall Metabolic Rate and Protein Synthesis In Vitro (2015) (17)
Misonidazole Combined with Split-Course Radiotherapy in the Treatment of Invasive Carcinoma of the Larynx and the Pharynx - A Preliminary Report of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 2 (1982) (17)
Step-down heating in a C3H mammary carcinoma in vivo: effects of varying the time and temperature of the sensitizing treatment. (1990) (17)
Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly (1999) (17)
Squamous cell carcinoma of the nasopharynx--an analysis of treatment results in 149 consecutive patients. (2001) (17)
Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts (2018) (17)
APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells. (2018) (17)
Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models. (2014) (17)
Biological Effect of 27.12-MHz Short-Wave Diathermic Heating in Experimental Tumors (1978) (17)
Influence of sampling time on assessment of potential doubling time. (1994) (16)
High-Resolution Melting Analysis for Mutation Screening of RGSL1, RGS16, and RGS8 in Breast Cancer (2010) (16)
Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum (2005) (16)
A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma (2019) (16)
Effect of radiation dose rate and cyclophosphamide on pulmonary toxicity after total body irradiation in a mouse model. (1996) (16)
Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo. (1991) (16)
Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure. (2017) (15)
Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab? (2010) (15)
Microcolony survival assay for jejunal crypt cells exposed to radiation alone and combined with cancer chemotherapeutic agents--methodological problems. (1983) (15)
Intracranial glossopharyngeal schwannoma, a tumour imitating an acoustic schwannoma. (1986) (15)
A century with hyperthermic oncology in Scandinavia. (1995) (15)
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen. (2004) (15)
In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors (2011) (15)
The effect of combining flavone acetic acid and hyperthermia on the growth of a C3H mammary carcinoma in vivo. (1991) (15)
Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study (2022) (15)
The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment. (1994) (15)
DAHANCA 19: First results of a randomized phase III study of the importance of the EGFR-inhibitor zalutumumab for the outcome of primary curative radiotherapy for squamous cell carcinoma of the head and neck (2013) (15)
Collagen fragment biomarkers as serological biomarkers of lean body mass – a biomarker pilot study from the DAHANCA25B cohort and matched controls (2015) (15)
Intracranial hypoglossal neurinoma: diagnosis and postoperative care. (1981) (15)
Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer. (1987) (15)
Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy. (1996) (14)
In normal human fibroblasts variation in DSB repair capacity cannot be ascribed to radiation-induced changes in the localisation, expression or activity of major NHEJ proteins. (2008) (14)
Stage and Survival in Breast Cancer Patients in Screened and Non-screened Danish and Swedish Populations (2003) (14)
Chemoradiotherapy of head and neck cancer--can the bumble bee fly? (2009) (14)
Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): Final analysis (2004) (14)
Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration (2018) (14)
Effect of local hyperthermia on the acute toxicity of misonidazole in mice. (1979) (14)
Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models. (2006) (14)
Advancing radiation oncology through scientific publication--100 volumes of Radiotherapy and Oncology. (2011) (14)
The Design of Clinical Trials in Hyperthermic Oncology (1987) (14)
Have choroidal and ciliary body melanomas changed during the period 1955-2000? (2004) (13)
Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000–2009 (2016) (13)
Radiotherapy: Gazing at the crystal ball of European radiotherapy (2015) (13)
Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the danish breast cancer cooperative group DBCG 82bc trial. (2022) (13)
THE DANISH HEAD AND NECK CANCER STUDY GROUP (DAHANCA) RANDOMIZED TRIALS WITH HYPOXIC RADIOSENSITIZERS IN CARCINOMA OF THE LARYNX AND PHARYNX (1992) (13)
Expert reviews, systematic reviews and meta-analyses. (2002) (13)
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond (2020) (12)
Late renal damage after total body irradiation and bone marrow transplantation in a mouse model: effect of radiation fractionation. (1995) (12)
The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay. (1988) (12)
Joint statement of mission by the RTOG/EORTC working groups (1995) (12)
Renal damage after total body irradiation in a mouse model for bone marrow transplantation: effect of radiation dose rate. (1995) (12)
International Clinical Trials in Radiation Oncology. Hyperthermia trials. (1988) (12)
Does age affect prognosis in salivary gland carcinoma patients? A national Danish study (2016) (12)
Breast cancer survival advantage with radiotherapy (2000) (12)
Randomised controlled trials in HBO: "A call to arms" for HOPON & DAHANCA-21. (2011) (12)
TP53 mutation is an independent prognostic marker for poor outcome of radiotherapy in squamous cell carcinoma of the head and neck (1998) (12)
Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study. (2016) (12)
Tumourigenicity and radiation resistance of mesenchymal stem cells (2012) (12)
Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013 (2020) (12)
Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours. (1996) (12)
Nodal control and surgical salvage after primary radiotherapy in 1 782 patients with laryngeal and pharyngeal carcinoma (2004) (12)
[DAHANCA (Danish Head and Neck Cancer)--20 years of cooperation]. (1998) (11)
Erythrocyte sedimentation rate--a predictor of malignant potential in early prostate cancer. (1997) (11)
Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group. (2016) (11)
Continuous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix. (1994) (11)
Quantitative assessment of radiation-induced lung changes by computerized optical densitometry of routine chest x-rays. (1996) (11)
Long-term evaluation of postmastectomy breast reconstruction with the pedicled transverse rectus abdominis musculocutaneous flap (2013) (11)
The effect of sequence and time intervals of combined hyperthermia and radiation treatment. (1977) (11)
TOP2A aberrations as predictive and prognostic marker in high-risk breast cancer patients. A randomized DBCG Trial (DBCG89D). (2006) (11)
Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection (2013) (11)
Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly (1999) (10)
Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia. (1995) (10)
Study of the population pharmacokinetic characteristics of nimorazole in head and neck cancer patients treated in the DAHANCA-5 trial. (2015) (10)
Antiproton radiotherapy. (2008) (10)
Effect of step-down heating on the interaction between heat and radiation in a C3H mammary carcinoma in vivo. (1991) (10)
Predictive classifier for intensive treatment of head and neck cancer (2020) (10)
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity. (2020) (10)
Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking (2020) (10)
Measurement of pO2 in a murine tumour and its correlation with hypoxic fraction. (1994) (10)
Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer (2018) (10)
Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapy. (1989) (10)
The effect of sequence and time interval between cyclophosphamide and total body irradiation on lung and bone marrow damage following bone marrow transplantation in mice. (1993) (9)
IMRT - Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. (2018) (9)
Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality (2015) (9)
A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma (2016) (9)
Improving radiotherapy of squamous cell carcinoma of the head and neck (HNSCC) through a continuous process of biological based clinical trials − a 40-year experience from the Danish Head and Neck Cancer Group − DAHANCA (2017) (9)
Photodynamic therapy of experimental intraocular retinoblastomas — dose‐response relationships to light energy and Photofrin II (1989) (9)
Simultaneous and Sequential Treatment with Radiation and Hyperthermia: A Comparative Assessment (1992) (9)
Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224). (2020) (9)
Danish retinoblastoma patients 1943–2013 – genetic testing and clinical implications (2016) (9)
Validation of a gene expression profile predictive of the risk of radiation-induced fibrosis in women treated with breast conserving therapy (2015) (9)
European School of Oncology Advisory Report to the Commission of the European Communities for the "Europe Against Cancer Programme." Continuing Medical Education in Oncology within the European Union. (1994) (9)
Education in radiation oncology in Europe. (1992) (9)
Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort (2016) (9)
Hydralazine-induced changes in tissue perfusion and radiation response in a C3H mammary carcinoma and mouse normal tissues. (1991) (9)
Late neurological complications after irradiation of malignant tumors of the testis (2007) (9)
DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051) (2019) (9)
Management of the Axilla in Breast Cancer, Implication for Diagnosis, Prognosis, Treatment, and Morbidity (2000) (9)
Invasive blood pressure measurements in restrained but non-anaesthetized mice. (1990) (8)
Histopathological and morphometric analyses of late rectal injury after irradiation (2000) (8)
Association between in vivo iododeoxyuridine labeling, MIB‐1 expression, malignancy grade and clinical stage in human prostate cancer (1998) (8)
Misonidazole neuropathy A prospective study (1988) (8)
The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma. (1995) (8)
Effect of combined 5-fluorouracil and radiation on murine hematopoietic tissue. (1988) (8)
Reproductive death of cancer cells induced by femtosecond laser pulses (2007) (8)
Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1–3 Positive Lymph Nodes? (2011) (8)
Early and late changes in the normal mouse bladder reservoir function due to irradiation and cis-DDP. (1992) (8)
Early and Late Effects of Irradiation on Morphometry and Residual Strain of Mouse Rectum (2002) (8)
Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer (2003) (8)
A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour. (1996) (8)
OC-009: Update of the randomised phase III trial DAHANCA 19: Primary C-RT or RT and zalutumumab for squamous cell carcinomas of head and neck (2015) (8)
Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays (2013) (8)
Fibroblast growth in the soft agar clonogenic assay for cervix cancer radiosensitivity. (1998) (7)
DAHANCA 9: a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (2013) (7)
Proliferative response of mouse spermatogonial stem cells after irradiation: a quantitative model analysis of experimental data (1996) (7)
FDG-PET reproducibility in tumor-bearing mice: comparing a traditional SUV approach with a tumor-to-brain tissue ratio approach (2017) (7)
The Danish Head and Neck Cancer Study Group DAHANCA : Past, Present and Future-a continuous process of clinical trials (2004) (7)
Importance of nicotinamide dose on blood pressure changes in mice and humans. (1994) (7)
674 Topoisomerase II alpha (TOP2A) alterations as a predictive marker for epirubicin sensitivity in 805 high-risk breast cancer patients. A randomised DBCG trial (DBCG89D) (2003) (7)
A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA) (2010) (7)
The european core curriculum on radiotherapy (1992) (7)
Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation? (1994) (7)
Uveal malignant melanoma. An ophthalmological or oncological disease? (2009) (7)
DAHANCA 9 – a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) (2019) (7)
Anti-vascular effects of ZD6126 and the enhancement of radiation damage in a murine tumour (2002) (7)
International Journal of Hyperthermia (2002) (7)
The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice. (1994) (7)
A facility for tumour therapy and biomedical research in South-Eastern Europe (2019) (7)
Comparison of one-stage direct-to-implant with acellular dermal matrix and two-stage immediate implant-based breast reconstruction-a cohort study. (2020) (7)
Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients (2017) (7)
Major or local surgery for cure in early rectal and sigmoid carcinoma--a prospective evaluation. (1986) (6)
Feasibility of Detecting Hypoxia in Experimental Mouse Tumours with 18 F-fluorinated Tracers and (2000) (6)
Studies on fractionated hyperthermia in L1A2 tumour cells in vitro: response to multiple equal heat fractions. (1985) (6)
19LBA HPV-associated p16-expression and response to radiobiological modifications of radiotherapy in head and neck cancer: results from the randomised DAHANCA trials (2009) (6)
Synergistic cell cycle kinetic effect of low doses of hyperthermia and radiation on tumour cells. (1979) (6)
The relative biological effectiveness of antiprotons. (2016) (6)
Sinonasal cancer in Denmark 2008–2015: a population-based phase-4 cohort study from DAHANCA (2021) (6)
Time-course of the hazard of murine nephropathy induced by total-body irradiation. (2000) (6)
Is kidney the real dose-limiting organ after total body irradiation and bone marrow transplantation? (1993) (6)
Postmastectomy radiotherapy should be the standard of care for all women with involved axillary nodes (2007) (6)
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial (2018) (6)
ESTRO-Wolfsberg a synergistic approach towards modern radiobiology. (2005) (6)
Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumes (2019) (6)
ATM sequence variants and adverse radiotherapy response in breast cancer patients (2004) (6)
BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma. (1992) (6)
Translational research in radiotherapy - getting closer to the bedside. (2007) (6)
Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo. (1986) (6)
Localized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reduction (1999) (6)
Leveraging clinical performance by technological excellence - The case of particle therapy. (2010) (6)
Rethink radiotherapy – BIGART 2017 (2017) (6)
Gene-expression Classifier in Papillary Thyroid Carcinoma: Validation and Application of a Classifier for Prognostication. (2016) (6)
29 Erythropoletin improves the oxygen carrying capacity of mouse blood without changing hypoxia in a murine tumour model (2003) (6)
Repair capacity of mouse lung after total body irradiation alone or combined with cyclophosphamide. (1996) (5)
Impact on Radiotherapy (2010) (5)
Molecular radiation biology/oncology at its best: cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. (2013) (5)
Investigating the potential of deep learning for patient-specific quality assurance of salivary gland contours using EORTC-1219-DAHANCA-29 clinical trial data (2021) (5)
Experimental studies of photodynamic therapy in a retinoblastoma‐like tumour (1987) (5)
Hyperthermia in vivo. Time-temperature relation and split dose effect. Abstr. (1977) (5)
Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database. (2020) (5)
Predictors of continuous tobacco smoking in a clinical cohort study of Danish laryngeal cancer patients smoking before treated with radiotherapy (2015) (5)
Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients (2017) (5)
Histologic and histochemical reactions in a mouse mammary carcinoma following exposure to combined heat-roentgen irradiation. (1975) (5)
Chapter 3 – Dose-Response Modifiers in Radiation Therapy (2012) (5)
Is there a role for hyperthermia in gastrointestinal tract cancer? (1988) (5)
SP-0315: Partial breast radiotherapy after breast conservation for breast cancer: early results from the randomised DBCG PBI trial (2017) (5)
Radiation-induced morbidity evaluated by high-frequency ultrasound (2016) (5)
Comparison of two T-classification systems for sino-nasal carcinoma. (2002) (5)
Is regional nodes radiotherapy an alternative to surgery? (2013) (5)
OC-0372: DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas (2014) (5)
OC-0148: Improved survival with internal mammary node irradiation: a prospective study on 3,072 breast cancer patients (2014) (5)
Deep heating using a movable applicator phased array hyperthermia system. A preclinical feasibility study. (1994) (5)
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV‐positive oropharynx cancer: Large‐scale comparison of DAHANCA vs PMH cohorts (2021) (4)
Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer (2007) (4)
Patterns in detection of recurrence among patients treated for breast cancer (2020) (4)
Is DBCG abreast of new developments? (2018) (4)
What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups (2017) (4)
OC-0142: Hypo- vs normofractionated radiation of early breast cancer in the randomised DBCG HYPO trial (2016) (4)
DBCG: The Danish Breast Cancer Cooperative Group – a 30-year struggle for better breast cancer treatment in Denmark (2008) (4)
Randomized study af ARANESP as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) - Final outcome of the DAHANCA 10 Trial (2010) (4)
[Prostatic cancer: an expensive dilemma]. (1997) (4)
Four decades with ESTRO. (2020) (4)
Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo. (1992) (4)
Tumour microenvironment and radiation response in sarcomas originating from tumourigenic human mesenchymal stem cells (2012) (4)
A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis (2022) (4)
Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervix (2021) (4)
44 The importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma is dependent on tumor differentiation (1995) (4)
Clinical Imaging of Hypoxia (2014) (4)
Lack of radiation protective effect of orgotein in normal and malignant mammalian cells. (1979) (4)
Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial (2022) (4)
The biological bases for the clinical application of hyperthermia as an adjuvant to radiotherapy. (1983) (4)
474 Plasma osteopontin (OPN) predicts hypoxia and response to the hypoxic sensitiser Nimorazole in radiotherapy of head and neck cancer. Results from the randomized DAHANCA 5 trial (2003) (4)
Radiotherapy & Oncology during the COVID-19 pandemic☆ (2020) (4)
23 : Accelerated Versus Conventional Fractionated Radiotherapy in Squamous Cell Carcinoma of the Head And Neck (SCCHN). A Randomized International Multicenter Trial With 908 Patients Conducted by the IAEA-ACC Study Group (2006) (4)
Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancer (2020) (4)
Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial. (2022) (4)
Epidermal growth factor and acute radiation damage in CDF1 mice in vivo. (1997) (4)
OC-041 DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC (2019) (4)
Impact of tobacco smoking on radiotherapy outcomes in 1875 HPV-positive oropharynx cancer patients. (2019) (4)
Characterization and radiosensitivity of fibroblasts derived from squamous cell carcinomas of the head and neck, and the surrounding oral mucosa. (1998) (4)
Bridging gaps in translational radiation oncology. (2006) (4)
Hyperfractioned or accelerated radiotherapy in head and neck cancer: a meta‐analysis (2007) (3)
Abstract S2-01: Importance of margin width and re-excision in breast conserving treatment of early breast cancer; a Danish breast cancer cooperative group study of 11,900 women (2016) (3)
Reinforcement of the abdominal wall with acellular dermal matrix or synthetic mesh after breast reconstruction with the pedicled transverse rectus abdominis musculocutaneous flap. A prospective double-blind randomized study (2020) (3)
Testing the hypothesis: pretreatment oxygenation predicts radiation response in advanced head & neck squamous cell carcinoma (1999) (3)
What next? (2014) (3)
900 ORAL Are TGF-beta 1 polymorphisms potential predictors of fibrosis risk after radiotherapy? – a subset analysis from the DAHANCA 6 and 7 protocols (2007) (3)
Salivary Gland Carcinoma in Denmark 1990‐2005: Incidence, Histology, Outcome and Prognostic Factors. Results of the Danish Head and Neck Cancer Group (DAHANCA) (2012) (3)
Improving anti-cancer therapy by targeting the tumour vasculature with combretastatins (1999) (3)
416Predictive assays in radiotherapy The Aarhus experience oxygenation status, cell kinetics and 31P MR spectroscopy in human soft tissue sarcomas (1996) (3)
Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1. (2021) (3)
Histological and histochemical studies on combined heat-roentgen treatment of a C3H mouse mammary carcinoma (2004) (3)
A comparison between the effect of step-down heating in a tumour and a normal tissue in vivo. (1991) (3)
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole (2015) (3)
Influence of Hyperthermia on the Immune Status: Experimental Basis and Clinical Application in Cancer Patients (1979) (3)
COMORBIDITY AMONG 13,651 HEAD AND NECK CANCER PATIENTS FROM THE DAHANCA-DATABASE (2011) (3)
Biological modeling in thermoradiotherapy: present status and ongoing developments toward routine clinical use (2022) (3)
Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing (2019) (3)
Bridging the valley of death: The new Radiotherapy & Oncology section "First in man - Translational innovations in radiation oncology". (2016) (3)
Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC). (2019) (3)
Living with heritable retinoblastoma and the perceived role of regular follow-up at a retinoblastoma survivorship clinic: ‘That is exactly what I have been missing’ (2021) (3)
8500 Expression of EGFR and HPV-associated p16 in head and neck cancer: correlation and influence on prognosis after radiotherapy in 1088 patients from the randomised DAHANCA 5,6&7 trials (2009) (3)
Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort (2021) (3)
Subglottic squamous cell carcinoma in Denmark 1971–2015 – a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group (2019) (3)
Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database (2021) (3)
Association of Smoking, Comorbidity, Clinical Stage, and Treatment Intent With Socioeconomic Differences in Survival After Oropharyngeal Squamous Cell Carcinoma in Denmark (2022) (3)
The management and survival outcomes of nasopharyngeal cancer in the Nordic countries* (2017) (3)
Randomized trial evaluating the role of blood transfusion prior to radiotherapy in 414 patients with head and neck carcinoma. A multicenter study by the Danish Head and Neck Cancer Study Group (DAHANCA) (1999) (2)
Chalkley estimates of angiogenesis in early breast cancer--relevance to prognosis. (2002) (2)
Effects of step-down and step-up heating on the development of thermotolerance in a C3H mammary carcinoma in vivo. (1995) (2)
FAZA PET hypoxia as a marker of loco-regional recurrence in HNSCC? Results from the DAHANCA 24 trial (2018) (2)
Radiation oncology in the new virtual and digital era (2020) (2)
Cancer suspicion in general practice , urgent referral and time to diagnosis : 1 A population-based cross-sectional study 2 (2014) (2)
OC-0597: Tumor-infiltrating lymphocytes predicts improved overall survival after post-mastectomy radiotherapy (2018) (2)
Application of microarray analyses to identify genes involved in radiation-induced fibrosis (2005) (2)
Does the combination of hyperthermia with low LET (linear energy transfer) radiation induce anti-tumor effects equivalent to those seen with high LET radiation alone? (2021) (2)
[Malignant parotid tumors. Therapeutic results and prognosis in 110 consecutive patients]. (1993) (2)
Breast cancer radiation therapy (2020) (2)
Corrigendum to “Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review” [Radiother. Oncol. 90 (2009) 1–13] (2011) (2)
Hyperthermic oncology, 1984 : proceedings of the 4th International Symposium on Hyperthermic Oncology, held at Aarhus, Denmark, 2-6 July 1984 (1984) (2)
Improved Treatment of Tumours in vivo by Combining the Bioreductive Drug RSU-1069, Hydralazine and Hyperthermia (1990) (2)
OC-0102 DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts (2022) (2)
The course and prognosis for loco-regional recurrences among high-risk breast cancer patients receiving adjuvant systemic treatment and randomized to +/− postmastectomy radiotherapy. Long-term results from the Danish DBCG 82b&c studies with 3083 patients (2004) (2)
Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy (2020) (2)
Reduction of Cisplatinum-Induced Renal Toxicity in Mice by Tetrahydroindazolone Carboxylic Acid (HIDA) (1993) (2)
17 Is the LENT-SOMA scoring system useful to record late rectal morbidity? (2000) (2)
Introduction: towards predicting outcome of radiotherapy-at last. (2012) (2)
243 Clinical significance of tumour hypoxia (2004) (2)
Hypo- vs normofractionated radiation therapy of early stage breast cancer in the randomized DBCG HYPO trial (2017) (2)
258Predictive assays in radiotherapy The Aarhus experience in vitro radiosensitivity in SCC of the head & neck (1996) (2)
OC-0057: Meta-analysis of radiotherapy in head and neck cancers: exploratory analysis according to patient characteristics (2014) (2)
Current Cancer Therapy Reviews (2004) (2)
Second cancers after radiotherapy for early breast cancer. (2015) (2)
Resistance training and dietary supplements as intervention for regaining muscle mass following radiotherapy in head and neck cancer patients (2011) (2)
Predictive value of flow cytometric DNA‐analysis on fresh retinoblastoma tissue (1988) (2)
HYPOXIC GENE EXPRESSION WITH PROGNOSTIC AND PREDICTIVE IMPACT FOR HYPOXIC MODIFICATION IN HEAD AND NECK CANCER (2011) (2)
Hypoxia and hemoglobin as prognostic markers of survival in head & neck carcinoma after primary radiation therapy. An international multi-center study (2001) (2)
Validating the use of CAIX and GLUT1 as endogenous markers for hypoxia in solid tumors (2005) (2)
OC-0278 Accelerated CH-RT with/without nimorazole for p16- HNSCC: the randomized DAHANCA 29-EORTC 1219 trial (2021) (2)
131 oral THE INFLUENCE OF COMORBIDITY, SMOKING BEHAVIOUR AND HUMAN PAPILLOMAVIRUS ON OVERALL SURVIVAL IN 1091 PATIENTS WITH OROPHARYNGEAL CARCINOMA: THE DAHANCA EXPERIENCE (2011) (2)
In response to the commentary ‘Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible’ by Thomas Friedrich, Marco Durante & Michael Scholz (2013) (2)
Can CA IX be used as an endogenous marker of hypoxia in HNSCC? An evaluation of the dahanca 5 study (2007) (1)
Differentiation patterns of secondary skin fibroblasts from radiotherapy patients with different degrees of radiation-induced skin fibrosis (1997) (1)
Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC). (2018) (1)
20 Identification of hypoxia regulated genes unaffected by pH (2008) (1)
Abstract P3-04-03: A seven-gene profile predicting benefit of postmastectomy radiotherapy independently of nodal status in high risk breast cancer (2012) (1)
Hypoxia and Radiation Therapy (2014) (1)
[Postoperative radiotherapy in cancer of the rectum and rectosigmoid. A prospective randomized multicenter study]. (1988) (1)
BIGART 2019 – adapting to the future (2019) (1)
The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas. (1995) (1)
Nasal vestibule squamous cell carcinoma: a population-based cohort study from DAHANCA (2021) (1)
[Centralized follow-up of patients treated for head and neck cancer]. (1997) (1)
Hyperthermia in Tumor Treatment (1989) (1)
1065 A randomized trial with 1485 patients evaluating the importance of accelerated versus conventional fractionated radiotherapy in squamous cell carcinoma of the head and neck. Final results of the DAHANCA 6&7 study (2003) (1)
HYPERTHERMIA IN CANCER TREATMENT. AUTHORS' REPLY (1995) (1)
Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis (2014) (1)
SP-033: Randomized Study of Darbepoetin Alfa as Modifier of Radiotherapy in Patients SCCHN. Final Outcome of the Dahanca 10 Trial (2013) (1)
[Prognosis in synchronous liver metastasis from colorectal cancer. A multicenter study of patients with cancer of the rectum and cancer of the rectosigmoid colon]. (1989) (1)
Bcl-2/p53 expression and TP53 mutations: Correlations with in vitro radiosensitivity in patients with head and neck squamous cell carcinoma (1997) (1)
Intense inflammation in bladder carcinoma indicate good prognosis (2001) (1)
Enhancing radiation therapy when the CO2 content of carbogen is reduced from 5% to 2% (2001) (1)
Cancer registration in the Arctic--a useful research tool. (1996) (1)
In vitro radiosensitivity of normal human skin fibroblasts correlates with the development of subcutaneous fibrosis after radiotherapy (1993) (1)
8503 ORAL A Prospective Study Evaluating the Influence of Smoking on Effective Hemoglobin Level and Outcome in Patients With Squamous Cell Carcinoma of the Head and Neck (2011) (1)
No correlation between radiation-induced permanent G1-arrest and radiosensitivity of normal human fibroblasts (2000) (1)
PD-026: Correlation and prognostic impact of HPV and p16 on RT-outcome in larynx and hypopharynx cancer (2017) (1)
Survival after enucleation and radiation brachy therapy for choroidal and ciliary body melanomas (2005) (1)
Thermoradiotherapy of Malignant Melanoma (1996) (1)
Hyperthermia in cancer treatment (1995) (1)
OC-0371: Hypo- vs normofractionated radiation of early breast cancer in the randomized DBCG HYPO trial (2020) (1)
Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study (2014) (1)
Hypoxia and local tumour control in squamous cell carcinoma of the anus – a hypothesis-generating study (2022) (1)
Effect of continued tobacco smoking during radiotherapy on loco-regional control for carcinoma of the larynx (2015) (1)
INTERACTION OF HYPERTHERMIA AND RADIATION IN SOLID TUMOURS IN VIVO (1992) (1)
The aggressiveness of hypoxic soft tissue sarcomas cannot be explained by mutations in the TP53 gene (1999) (1)
Fast track for head and neck cancer patients: The story of the Danish national strategy for accelerated diagnosis and treatment of cancer (2011) (1)
OC-0052: Long-term age dependent failure pattern after BCT vs. mastectomy in low-risk breast cancer patients (2016) (1)
Correlation and prognostic impact of human papilloma virus and p16-expression in advanced hypopharynx and larynx cancer treated with definitive radiotherapy (2021) (1)
Steel-Alumina MMC Billets Manufactured by Sprayforming (1993) (1)
Effect of HPV on Treatment Outcome and Survival in Oropharyngeal Carcinoma - a Subgroup Analysis of the Randomized DAHANCA 5&7 Trials (2008) (1)
141 The clinical, physical and radiobiological aspects of total body irradiation (1995) (1)
A proteomic analysis of the effect of radiation therapy on wound healing in women reconstructed with the TRAM flap (2013) (1)
Running title: Functional proteomics of human breast tumors Title: A novel approach to the study of the functional proteome in breast cancer Running title: Functional proteomics of human breast tumors (2008) (1)
Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency (2019) (1)
P20 14 MP – EFFECTS OF STEP-DOWN AND STEP-UP HEATING ON THE DEVELOPMENT OF THERMOTOLERANCE IN A C3H MAMMARY CARCINOMA IN VIVO (1991) (1)
8507 The EGFRvIII variant in squamous cell carcinomas of the head and neck: Expression and correlation with clinico-pathological parameters in 675 patients from the randomised DAHANCA 6/7 study (2009) (1)
Re: Jens Overgaard. Ultrastructure of a Murine Mammary Carcinoma Exposed to Hyperthermia in Vivo. Cancer Res., 36: 983–995, 1976 (1977) (1)
Intrinsic subtype characterization of local recurrences and new contralateral primary tumors in patients with low risk breast cancer. Influence of age and primary surgery (2017) (1)
1 Radiation morbidity in cancer care — the size of the problem (2000) (1)
Hypothyroidism After Primary Radiation Therapy in Squamous Cell Carcinoma of the Head and Neck (HNSCC) (2012) (1)
751 Correlation of copy number, gene and protein expression for breast cancer related genes and proteins (2010) (1)
Oncoplastic breast surgery versus conventional breast conserving surgery – a prospective follow-up study of subjective loco-regional late morbidity (2021) (1)
OC-0489: Risk of second primary lung cancer in women after radiotherapy for breast cancer; a DBCG based dose-response study (2014) (1)
RE: Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival. (2018) (1)
104 The prognostic value of pimonidazole & tumor pO2 in human cervix carcinomas after radiation therapy: An international multi-center study (2006) (1)
72 ANTIPROTONS FOR RADIOBIOLOGY AND CANCER THERAPY THE AD-4/ACE EXPERIMENT (2012) (1)
The oxygen effect and therapeutic approaches to tumour hypoxia (2018) (1)
The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice. (2022) (1)
The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation. (1990) (1)
[Local treatment of cancer of the breast]. (1981) (1)
SP-0251 IMPORTANCE OF AGE AND CO-MORBIDITY FOR THE OUTCOME OF RADIOTHERAPY IN HEAD AND NECK CANCER: A POPULATION BASED STUDY (2012) (1)
OC-0149 HPV, SMOKING AND RT-OUTCOME IN ADVANCED OPC TREATED WITHOUT CHEMOTHERAPY – ANALYSIS OF DAHANCA PATIENTS (2012) (1)
OC-0271: 5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT +/- zalutumumab in HNSCC (2018) (1)
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors (2013) (1)
EP-1155: Radiation-induced morbidity evaluated by high-frequency ultrasound: a pilot study (2016) (1)
[Angiogenesis: prognostic marker in prostatic cancer]. (1999) (1)
Radiotherapy with or without mitomycin C in the treatment of locally advanced head and neck cancer. Results from the IAEA multicentre randomised trial (2001) (1)
28 Radiotherapy and concomittant mitomycin c(MMC) for locally advanced head and neck cancer. Final report of the IAEA multicentre randomized trial (2003) (1)
SP-0219: Green Journal (2016) (0)
DAHANCA 27 - Transoral Laserassisteret Mikrokirurgi (TLM) ved T1aN0M0 glottiscancer. (2018) (0)
Risk stratification after introduction of sentinel lymph node biopsy technique — A population based DBCG study (2006) (0)
Syddansk Universitet Role of radiotherapy fractionation in head and neck cancers ( MARCH ) an updated meta-analysis (2017) (0)
OC-0922 Socioeconomic inequality in survival after oropharyngeal cancer – a nationwide study from DAHANCA (2022) (0)
External validation of a mixture NTCP model of radiation-induced hypothyroidism (HT). (2016) (0)
P16 22 MP – MODIFICATION OF THE IN VIVO RESPONSE TO FRACTIONATED IRRADIATION BY NORMOBARIC OXYGEN, CARBOGEN OR CARBON MONOXIDE BREATHING (1991) (0)
17 Can danish breast cancer patients by early diagnosis achieve the same survival as observed in Sweden? A study in screened and non-screened Danish and Swedish populations (2003) (0)
OC-0832 DAHANCA 27, a national prospective non-inferiority study of surgery versus RT for T1a glottic cancer (2022) (0)
Social inequality in continuous tobacco use when treated with radiotherapy: A clinical cohort study of danish laryngeal cancer patients in 2000-2010 (2015) (0)
778 UPA and PAI-1 are associated with angiogenesis but not prognosis in non-small cell lung carcinoma (2003) (0)
356 Genetic variation in relation to adverse side-effects of radiotherapy – focus on the metabolism of reactive oxygen species (2010) (0)
HPV-associated P16 positive head and neck squamous cell carcinomas exhibit improved prognosis and response to radiotherapy (2007) (0)
721 Risk of second primary cancer in hereditary and non-hereditary retinoblastoma: results from a population based study with more than 40 years follow-up (2003) (0)
Personalized Medicine and Imaging Development and Validation of a Gene Pro fi le Predicting Bene fi t of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer : A Study of Gene Expression in the DBCG 82 bc Cohort (2014) (0)
PO-1925 In vitro characterisation of the bacteria-derived hypoxia-selective cytotoxin BE-43547 (2021) (0)
128 HYPOXIC MODIFICATION OF RADIOTHERAPY WITH NIMORAZOLE IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: IMPORTANCE OF COMBINED HYPOXIA AND HPV (2012) (0)
1050PD Phase Ib/II, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naı̈ve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) (2018) (0)
Wound Healing – A Proteomic Analysis of the Effect of Erythropoietin on Granulation Tissue Isolated from ePTFE Implants - (2014) (0)
Patterns in detection of recurrence among patients treated for breast cancer. (2020) (0)
The role of blood transfusion prior to radiotherapy in patients with HNSCC - Evaluation of DAHANCA 5&7 randomized trials (2008) (0)
6 Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage (2008) (0)
Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositis. (2021) (0)
74 Enhancement of radiation damage in murine tumours and normal tissues using clinically relevant doses of nicotinamide (1996) (0)
PD-032 Incidence and management of laryngeal squamous cell carcinoma in the Nordic countries (2019) (0)
OC-036: Resistance Training and Dietary Supplements in Radiotherapy Treated Head and Neck Cancer Patients (DAHANCA 25A) (2013) (0)
2021 Enhancing local tumour control by combining radiation therapy and the vascular targeting drug combretastatin A-4 disodium phosphate (1999) (0)
The influence of HPV associated p16-expression on response to accelerated fractionation in radiotherapy of head and neck cancer. Evaluation of the randomised DAHANCA 6&7 trial (2010) (0)
PO-0798: Early mortality after radical radiotherapy in head and neck cancer (2020) (0)
Modification of hypoxia in radiotherapy overview of the problem (1993) (0)
A Validation Study of Normal Tissue Complication Probability (NTCP) Models for Radiation-Induced Hypothyroidism (HT) (2014) (0)
OC-0329: Does margin matter? Distribution of locoregional failures after primary IMRT for Head & Neck cancer (2017) (0)
Evaluation of comorbidity in 9388 head and neck cancer patients: A study from the DAHANCA database (2014) (0)
OC-0536: Darbepoetin alfa and radiotherapy in the treatment of SCCHN – the DAHANCA 10 randomized trial (2018) (0)
OC-0609: Patient specific plan QA for clinical trial EORTC 1219 using Knowledge-Based Planning (2018) (0)
9.08 – Tumor Hypoxia (2014) (0)
PD-042: Impact of Comorbidities in Charlson Comorbidity Index in 9,389 HNSCC Patients: Study from the Dahanca Database (2013) (0)
40: Do physiological relevant doses of biguanides have any role in cancer treatment? (2014) (0)
678 EGFr expression and histopathological differentiation influence the response to accelerated fractionation in squamous cell carcinomas of the head and neck (HNSCC). Analysis of 702 patients from the randomized DAHANCA 6 and 7 trial (2003) (0)
PH-0051 Outcomes after definitive (C)RT in HPV+ OPC: Largescale comparison of two population-based cohorts (2021) (0)
62 INVITED Time, dose and fractionation in squamous cell carcinoma – business as usual? (2007) (0)
In Regards to Stokes et al and Bledsoe et al. (2017) (0)
OC-0325: Postmastectomy RT in high-risk breast cancer. A 30-year update of the DBCG 82bc randomized trial. (2020) (0)
835 Modification of the sparing effect of using low dose rate total body irradiation on murine pulmonary toxicity by cyclophosphamide (1995) (0)
609 Tumour burden and interleukin-2 dose affect the synergism between low-dose total body irradiation and interleukin-2 (2003) (0)
MO-0480 Risk of acute mucositis following an increase in high dose CTV1 in HNSCC patients (2022) (0)
University of Southern Denmark Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients (2017) (0)
P IX.5 Variation of radiosensitivity and dsb repair does not correlate with the Ku70/80 and DNA-PK activity in normal human fibroblasts (1997) (0)
Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV+ oropharynx cancer: Large scale comparison of two population-based cohorts (2021) (0)
Implementation of a 15-gene hypoxia classifier in Head and Neck Cancer (2015) (0)
OC-0450: Failure pattern and salvage treatment after radical treatment of head and neck cancer (2016) (0)
PO-103: Oropharyngeal cancer patient-derived xenografts: Characterization and radiosensitivity. (2017) (0)
MultifractionatedHyperthermiaTreatment of Malignantand Normal Tissue in Vivo1 (2006) (0)
SP-0339 Cancer epidemiology in Europe with focus on indications for RT (2019) (0)
OC-0504 CD8 positive cells indicate gain of postmastectomy radiotherapy: a study of the DBCG82bc cohort (2022) (0)
Abstract LB-61: Comparative study of different diagnostic techniques (AI, MLPA, FISH) in breast cancer patients with 1q25.3 alterations (2010) (0)
SP-0373 QUANTIFYING HYPOXIA IMAGING TO IMPROVE RADIOTHERAPY OUTCOME (2012) (0)
EP-2056: Preclinical investigation of hypoxia induced genes in different prostate cancer cell lines (2016) (0)
SP-0645: Future changes and challenges in oncology and the role of the medical physicist (2013) (0)
Occurrence of paired cisternae in the cytoplasm of interphase murine mammary carcinoma cells (1976) (0)
18F-fluoroazomycin arabinosid (FAZA) PET in patients with head and neck squamous cell carcinoma (HNSCC) (2011) (0)
Genetic testing in adult survivors of retinoblastoma in Denmark: A study of the experience and impact of genetic testing many years after initial diagnosis. (2022) (0)
MO-0383 A validated prognostic genetic profile independent of smoking in HPV-positive oropharynx cancer (2022) (0)
OC-0271 Hypoxia in anal cancer – a hypothesis generating study using a 15-gene hypoxia classifier (2022) (0)
SP-0613 USE IN CLINICAL TRIALS (2012) (0)
P15 25 MP – FRACTIONATION SENSITIVITY AND LATENCY OF LATE RADIATION INJURY TO THE MOUSE URINARY BLADDER (1991) (0)
648 Prognostic significance of UPA and PAI-1 in relation to other prognosticators for the clinical outcome of breast cancer (1995) (0)
OC-0388 A prospective multicenter DAHANCA study of hyperfractionated accelerated RT for head and neck cancer (2019) (0)
Squamous cell carcinoma of the oral cavity in Denmark 2004-2008 - a nationwide study from DAHANCA (2011) (0)
DAHANCA 27: Transoral laser assisted microsurgery for T1a glottic cancer (2018) (0)
460 A Seven-gene Signature Predicting Benefit of Postmastectomy Radiotherapy in High Risk Breast Cancer (2012) (0)
Overview Hyperthermia : a Potent Enhancer of Radiotherapy (2008) (0)
Anorectal dysfunction following adjuvant postoperativ radiotherapy for rectal cancer (2000) (0)
DANGLOT og DAHANCA 27 - National database for patienter med laryngeal intraepitelial neoplasi (LIN) og T1A-glottiscancer samt opstart af kirurgisk behandling af T1A-glottiscancer (DAHANCA 27): Status 2015 (2015) (0)
PD-0357 DEPENDENCE OF CELL SURVIVAL ON THE INSTANTANEOUS DOSE RATE OF A LINEAR ACCELERATOR (2012) (0)
Risk of Severe Radiation Morbidity in Radiotherapy Trials: A Critical Evaluation of the TAME Risk Classification System (2007) (0)
Symposium on risk factors and mechanisms in carcinogenesis. June 26-28, 1989, Wurzburg, West Germany. Proceedings. (1990) (0)
822 Assessment of human fibroblast radiosensitivity by the micronucleus and colony-forming assay (1995) (0)
PO-1408 Establishment of a national database for non-melanoma skin cancer treated with radiotherapy (2021) (0)
PO-084: Locally Advanced Head and Neck Cancer Treated with Accelerated Radiotherapy, Nimorazol and Weekly Cisplatinum. (2013) (0)
2031 ORAL A comparison between HER2, p53, PAI-1, angiogenesis and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer (2007) (0)
Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays (2012) (0)
Hypothyroidism after primary radiotherapy in carcinoma of the head and neck (HNSCC) (2012) (0)
Abstract 4958: AMPK as a target to overcome hypoxia-induced treatment resistance in tumors. (2013) (0)
110 poster: Hypoxia Pet Imaging: Static Versus Dynamic Scans (2010) (0)
A23 Instructional Session: New developments in radiotherapy (2010) (0)
Detection of TP53 mutations by denaturing high-performance liquid chromatography (2001) (0)
SP-0010 Robert Kienbˆck and Gottwald Schwarz - Pioneers of radiobiology and clinical radiotherapy (2014) (0)
Risk of recurrence from papillary thyroid microcarcinoma by method of discovery (2015) (0)
Hypoxia and its modification (2001) (0)
25th volume anniversary (1992) (0)
EARLY BREAST CANCER (1979) (0)
Impact of Tobacco Smoking on Mutational Landscape in HPV-Associated Oropharyngeal Cancer (2018) (0)
ATM rs1801516 SNP and toxicity after radiotherapy (2017) (0)
1160 POSTER Induction of Hypoxia by Vascular Disrupting Agents and the Significance for Their Combination With Radiation Therapy (2011) (0)
Papillary thyroid cancer in Denmark 1996‐2008: Is rising in‐cidence explained by increased detection rate? (2012) (0)
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome (2017) (0)
Human cervix carcinoma: a comparison between hypoxia measured by pimonidazole and invasive pO2 probes. An international multi-center study (2001) (0)
Papillary carcinoma in Denmark 1996-2008 (2014) (0)
OC-0588 Combing hyperthermia and/or OXi4503 with low LET radiation is equivalent to high LET radiation alone (2019) (0)
Importance of HER2 and receptor status on the response to adjuvant radiotherapy in high-risk breast cancer — Results from the DBCG82 b&c randomized study (2006) (0)
Subglottic Squamous Cell Carcinoma in Denmark 1971-2015: a report from the DAHANCA group (2017) (0)
OC-0435 Loco-regional failure is associated with the stem cell marker SLC3A2, volume and HPV/p16 in HNSCC (2022) (0)
105 Using 18F-fluoroazomycin arabinoside to non-invasively image hypoxia in human tumour xenografts: A comparative assessment with the eppendorf electrode and pimonidazole binding (2006) (0)
743 Understanding of treatment related late effects using radiation induced fibrosis as an example (2003) (0)
[Radiation induced malignant hypertension treated by unilateral nephrectomy]. (1976) (0)
Tumour Growth in mouse footpad - Model for radiotherapy and hyperthermia treatment (2002) (0)
OC-0434 Unknown Primary Head and Neck SCC: a phase-4 population-based cohort study from DAHANCA (2022) (0)
Optiv Fiber Invasive Hyperthermia (1993) (0)
PH-0607: Investigating the potential of deep learning for quality assurance of organ-at-risk contours (2020) (0)
PV-0425: Associations between rash, treatment outcome, and SNPs in HNSCC patients receiving EGFR-inhibition (2018) (0)
Predictors of continous Tobacco use when treated with radiotherapy - a clinical cohort study of Danish laryngeal cancer patients in 2000-2010 (2014) (0)
155Late effects on bowel function in patients undergoing adjuvant radiotherapy after anterior resection. A randomized study (1996) (0)
[Waiting for radiotherapy. Is it of prognostic significance?]. (2000) (0)
26 Single nucleotide polymorphisms in candidate genes correlate with clinical normal tissue radiosensitivity (2003) (0)
A tribute to the founding editor (2000) (0)
Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer. (2022) (0)
EP-1198 NASOPHARYNGEAL CANCER TREATED WITH ACCELERATED RADIOTHERAPY IN COMBINATION WITH NIMORAZOL AND WEEKLY CISPLATINUM (2012) (0)
DAHANCA 6: A randomised trial of five versus six fractions per week of radiotherapy in squamous cell glottic cancer - long term follow-up (2014) (0)
406 Carcinoma of the nasal cavity and paranasal sinuses: A retrospective study of 169 patients (1995) (0)
OC-021 Transoral Laser Microsurgery for T1a glottic cancer - DAHANCA 27 (2019) (0)
Sigvard Kaae - in memoriam (2002) (0)
OC-0084: SNP analysis on late radiation induced toxicity analyzed by anal physiological methods in prostate cancer patients (2015) (0)
Overcoming tumour radiation resistance resulting from acute hypoxia. (1992) (0)
A new workflow for methylation biomarker development: discovery and validation of 20 novel breast cancer methylation biomarkers (2013) (0)
SP-0505: Unexpected and under-estimated late toxicities with hypofractionation (2015) (0)
Status Report for Experiment AD-4/ACE (2011) (0)
Robustness and reliability of PET-based identification and quantification of tumor hypoxia, using simple static or more complex scan acquisitions (2016) (0)
Evaluation of the importance of haemoglobin level in the randomized DAHANCA 5 study (2010) (0)
Abstract 2308: Heterogeneous and low-level methylation of novel biomarker candidates for breast cancer clinical management (2014) (0)
[Heat therapy of malignant tumors. Effect of heat and combined heat-radiation therapy in an isologous anaplastic mouse mammary carcinoma]. (1973) (0)
PO-084: The pharmacokinetic characteristics of nimorazole in head and neck cancer patients treated in the DAHANCA-5 trial (2015) (0)
Molecular breast cancer prognosis in node negative early breast cancer. (2009) (0)
PV-0571: Transcriptomic changes in fibroblasts irradiated with proton beam scanning or Co-60 gamma rays (2018) (0)
PH-0048 Pattern of failure after curative (C-)RT in HNSCC: data from the phase III DAHANCA19 study (2021) (0)
143Predictive assays in radiotherapy The Aarhus experience cell kinetics in squamous cell carcinoma of the head & neck — Does it predict treatment outcome? (1996) (0)
OC-0056: The DAHANCA 6 randomised trial: Five versus six fractions per week of radiotherapy in glottic cancer (2014) (0)
The value of routine follow-up after treatment for head and neck cancer. A national DAHANCA study (2013) (0)
Robust PCR-quantification of RNA from formalin-fixed paraffin-embedded breast cancer tissue slides with variable tumor cell content (2008) (0)
EP-1100: External validation of a mixture NTCP model of radiationinduced hypothyroidism (HT) (2016) (0)
OC-0092 Enhanced RBE for late compared to early normal tissue damage in vivo (2022) (0)
117: Identification of DNA sequence variants associated with a gene expression profile predictive for radiation induced fibrosis (2014) (0)
Therelationship between carbon monoxide breathing, tumouroxygenation andlocal tumourcontrol intheC3H mammary carcinoma invivo (1994) (0)
5192 POSTER Breast Conserving Therapy – Morbidity and Cosmetic Outcome in DBCG Protocols TM-′89, -′99 and -′01 (2011) (0)
EP-1017: IAEA-HypoX: a randomized multicenter study of accelerated RT and the hypoxic radiosensitizer nimorazole in HNSCC (2013) (0)
Standardised cancer patient pathways (‘fast-track’) in Denmark: How is it used by the GP and what impact did ‘fast-track’ have on diagnostic interval across time? (2015) (0)
OC-0930 Breast induration versus irradiated breast volume in the randomized phase III DBCG PBI trial (2022) (0)
Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study (2021) (0)
PO-101 HPV, tobacco smoking and specific mutations and amplifications in oropharyngeal cancer (2019) (0)
701 Quantification of angiogenesis as a prognostic marker in 977 human carcinomas: A critical evaluation of the consensus on histopathological methods for estimation of vascular density (2003) (0)
PH-0288: Independent external validation of a logistic regression NTCP model for grade 3 oral mucositis (2020) (0)
PO-055: Subglottic squamous cell carcinoma in Denmark from 1971-2016 –a report from the DAHANCA-group (2017) (0)
102 Preclinical studies in murine tumours to elucidate the role of serum osteopontin as an endogenous marker of hypoxia (2006) (0)
SP-0092 ETHIC VALUES IN THE DISSEMINATION OF SCIENCE (2012) (0)
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients (2017) (0)
OC-0829 Acute toxicity after loco regional breast radiation therapy in the randomized DBCG SKAGEN trial 1 (2022) (0)
PO-081: A longitudinal study of follow-up activities after curative treatment for head and neck cancer (2015) (0)
Potential doubling time (T POT) in adenocarcinoma of the prostate (1997) (0)
8509 POSTER DISCUSSION Comorbidity in Radiotherapy-treated Head and Neck Cancer – the Impact of Individual Comorbidities on Survival (2011) (0)
OC-0376: FAZA PET/CT hypoxia imaging in patients with HNSCC treated with radiotherapy: results from the DAHANCA 24 trial (2014) (0)
PD-028: Prognostic and predictive impact of HPV status in oropharyngeal cancer: the MARCH-HPV project (2017) (0)
Breast cancer radiotherapy: is it time to rethink the indication? (2022) (0)
P16 21 MP – REPOPULATION AFTER IRRADIATION AND CHEMOTHERAPY IN A C3H MAMMARY CARCINOMA IN VIVO (1991) (0)
The DBCG RT PBI trial: Accelerated partial breast irradiation for early stage breast cancer, early results from 882 patients enrolled in a clinically controlled randomized phase III trial (2018) (0)
[Radiation enteritis: mucosal regeneration and stromal reaction of the small intestine after irradiation]. (1990) (0)
Can we predict the efficacy and side effect of radiotherapy (1999) (0)
OC-0283 LET dependence of proton RBE in early normal tissue damage in vivo (2021) (0)
Histology as a method of detecting biological heat damage in tumours. (1983) (0)
Hypoxic modification in radiotherapy (1997) (0)
No time to die – BiGART is back. The 20th Acta Oncologica Symposium – BIGART 2021 (2022) (0)
RBE for Carbon ions In Vivo for Tumor Control and Normal Tissue Damage (2016) (0)
Primary (chemo-) radiotherapy and concomitant EGFR-inhibitor zalutumumab to patients with squamous cell carcinoma of the head and neck. Results of the randomized phase III trial DAHANCA 19 (2014) (0)
P39 14 TP – TUMOR GROWTH AND VASCULARIZATION. A MATHEMATICAL MODELING STUDY OF THE C3H MOUSE MAMMARY CARCINOMA (1991) (0)
Treatment Outcomes and Survival Following Primary (chemo) Radiotherapy in HPV+ Oropharynx Cancer: A Largescale Comparison of Two Institutions (2019) (0)
PO-110: Analysis of loco-regional failures after IMRT for HNSCC using deformable image registration (2017) (0)
Abstract 1703: Discovery and validation of 20 novel breast cancer methylation biomarkers: A new workflow for methylation biomarker development (2012) (0)
37 Mesenchymal Cancer Stem Cells: Role in tumour development and radiotherapy resistance (2008) (0)
Carbon Ion Therapy: on the importance of target size for selective boosting of hypoxic tumor subvolumina (2010) (0)
PO-0964: Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials (2014) (0)
Evaluation of Movable Applicator Phase Array System (1992) (0)
Comorbidity among 12,623 Head and Neck Cancer patients from the DAHANCA database: A retrospective cohort study (2012) (0)
SP-0627: Against the motion: This house believes that standard fractionation will remain the standard-of-care for the majority of curative treatments by 2025 (2016) (0)
K7. Radiation oncology (2009) (0)
The effect of castration on tumour growth rate and cell kinetics in hormone-sensitive and hormone-insensitive rat prostatic adenomas (1999) (0)
Author ' s response to reviews Title : Cancer suspicion in general practice , urgent referral and time to diagnosis : A population-based cross-sectional study (2014) (0)
A prospective multicenter DAHANCA study of hyperfractionated accelerated RT for head and neck cancer (2019) (0)
395 Valid PCR quantification of mRNA from 16 year old formalin-fixed, paraffin-embedded breast cancer tissue: a methodological study comparing manually trimmed sections and whole tissue sections (2010) (0)
Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer (2005) (0)
Danish heritable retinoblastoma survivors' perspectives on reproductive choices: “It's important for me, not to pass on this condition” (2022) (0)
Resource utilization and patient reported outcomes using acellular dermal matrix in breast reconstructive procedures (2021) (0)
Altered fractionation in early glottic carcinoma (2017) (0)
Editorial: Fractionation in Radiotherapy (1988) (0)
SP-0250: Waiting time in radiotherapy, an overlooked problem (2017) (0)
Combretastatin A-4 disodium phosphate and mild hyperthermia: An effective combination for improving radiation therapy (2000) (0)
FACTORS ASSOCIATED WITH ACUTE AND LATE DYSPHAGIA IN THE DAHANCA 6 & 7 TRIAL (2011) (0)
S35 05 FA – INTERACTION OF HYPERTHERMIA AND RADIATION IN SOLID TUMOURS IN VIVO (1991) (0)
In vitro hypoxia responsiveness of [18F] FDG and [18F] FAZA retention: influence of shaking versus stagnant conditions, glass versus polystyrene substrata and cell number down-scaling (2020) (0)
MO-0382 Learning from every patient‘s biomarker - Stem cells, hypoxia, HPV and tumor volume in Dahanca 5 (2022) (0)
OC-0334 Partial vs whole-breast irradiation for breast cancer patients in the randomized DBCG PBI trial (2021) (0)
Nasopharyngeal cancer treated with accelerated radiotherapy in combination with hypoxic modification (nimorazole) and weekly cisplatinum (2008) (0)
The use of HIDA to improve the therapeutic ratio with trimodality therapy (1991) (0)
Interaction of etoposide and radiation in a C3H mammary carcinoma and the feet of CDF1 mice (1993) (0)
Therapeutics , Targets , and Chemical Biology Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer (2011) (0)
808 Poster 18f- FLUOROAZOMYCIN ARABINOSIDE (FAZA) PET IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) (2011) (0)
Combined modality therapy: clinical and laboratory aspects. (1982) (0)
103 Comparison of 18FMISO pet and polarographic oxygen electrode measurements in human tumours (2006) (0)
P29 12 WP – INFLUENCE OF DOSE ON THE REGENERATION OF MURINE HEMATOPOIETIC STEM CELLS AFTER TOTAL BODY IRRADIATION AND CHEMOTHERAPEUTIC DRUGS (1991) (0)
Reply to E. Avisar, H. Kuerer, L. Livi et al, and E. Hindié et al. (2016) (0)
Treatment of nasopharyngeal cancer in Denmark and outcome: results (2000) (0)
Fibroblast contamination in assays of tumour radio-sensitivity (1997) (0)
160Early and late lung changes after postmastectomy radiotherapy alone or combined with cyclophosphamide or CMF (1996) (0)
The Journal of JASTRO (2001) (0)
515 oral FAST TRACK FOR HEAD AND NECK CANCER PATIENTS: THE STORY OF THE DANISH NATIONAL STRATEGY FOR ACCELERATED DIAGNOSIS AND TREATMENT OF CANCER (2011) (0)
254Predictive assays in radiotherapy The Aarhus experience fibroblast radiosensitivity versus early and late normal tissue radiation response in patients with breast cancer (1996) (0)
Biological Effects of Antiprotons Are Antiprotons a Candidate for Cancer Therapy ? Status Report for Experiment AD-4 / ACE (2010) (0)
Hyperthermia as a modality in the treatment of cancer (1987) (0)
1097 Disease presentation and development in bladder cancer is related to outcome following radical cystectomy (2003) (0)
255Residual DNA double-strand breaks and cellular radiosensitivity of 12 normal human fibroblasts (1996) (0)
OC-0333: Prognostic impact of HPV and smoking in RT of oropharyngeal cancer: the MARCH-HPV project (2017) (0)
Serological peptide biomarkers derived from intramuscular connective tissue collagens are biomarkers of muscle mass (2014) (0)
Molecular Signatures of Local Control in Breast Cancer (2015) (0)
Prognostic Impact of HPV-Associated p16 Expression and Smoking Status on Outcomes Following Radiation Therapy for Oropharyngeal Cancer : the MARCH-HPV Project (2018) (0)
P16 26 MP – THE ELIMINATION OF BOTH CHRONIC AND ACUTE HYPOXIA IN TUMOURS (1991) (0)
SP-0341 Influence of age and comorbidity on outcome and compliance to RT (2019) (0)
Status Report and Beam Time Request for Experiment AD-4 Biological Effectiveness of Antiproton Annihilation (2007) (0)
Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment. (1993) (0)
417Predictive assays in radiotherapy The Aarhus experience Tumor oxygenation in SCC of the head & neck (1996) (0)
Programmed death-ligand 1 (PD-L1) expression and HPV-associated p16 in oropharyngeal squamous cell carcinoma (OSCC) treated with primary curative radiotherapy (RT). (2018) (0)
Reduction of cisplatinum-induced renal toxicity in mice by tetrahydroindazolonecarboxylic acid (HIDA) [corrected]. (1993) (0)
OC-0110 Characterisation of an inorganic scintillation detector system for time resolved in vivo dosimetry (2021) (0)
S17 01 TA – NIMORAZOLE AS A HYPOXIC RADIOSENSITIZER IN HEAD AND NECK CANCER (1991) (0)
Treatment of early carcinoma of breast. (1972) (0)
OC-0326: DBCG-IMN: Long-term survival gain with internal mammary node irradiation to breast cancer patients (2020) (0)
121 Is expression of the epidermal growth factor receptor related to hypoxia in squamous cell carcinomas of the head and neck - an evaluation of the dahanca 5 study (2006) (0)
OC-0061: Evaluation of comorbidity in 9,388 Head and Neck Cancer patients: A study from the DAHANCA database (2014) (0)
BE-43547 has in vivo anti-tumor activity in mouse tumor models (2018) (0)
Single particle detection for spectroscopic CT and tracking in hadron therapy using Medipix chips (2016) (0)
828 Effect of epidermal growth factor (EGF) on acute radiation damage to mouse intestine and epidermis in vivo (1995) (0)
82: An example of the integrated model: the EORTC DAHANCA-1219 trial (2014) (0)
P-70 Recurrence analysis of Danish patients with sinonasal cancer treated with IMRT in 2008–2015. A DAHANCA study (2021) (0)
851 Genetic variation in relation to adverse side effects of radiotherapy – focus on the metabolism of reactive oxygen species (2010) (0)
Hypothyroidism after radiotherapy (2015) (0)
PV-0430: Localisation of recurrences in the neck after IMRT for HNSCC in relation to the elective CTV (2018) (0)
SP-0189 Nation-wide app-based collection of PROs in early breast cancer patients treated with radiation therapy - The DBCG experience (2022) (0)
Target coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008–2015. A DAHANCA study (2022) (0)
Syddansk Universitet Collagen fragment biomarkers as serological biomarkers of lean body mass a biomarker pilot study from the DAHANCA 25 B cohort and matched controls (2015) (0)
365Radiotherapy of hypopharyngeal squamous cell carcinoma (1996) (0)
Low hemoglobin and transfusions, the effect on radiotherapy in head and neck cancer patients - Evaluation of DAHANCA 5 & 7 randomized trials (2009) (0)
308 oral SECOND PRIMARY CANCER AMONG DANISH WOMEN WITH EARLY BREAST CANCER TREATED WITH POSTOPERATIVE RADIOTHERAPY (2011) (0)
Proteomic Predictors of Outcome After Adjuvant Anti-Hormonal Therapy for Hormone Receptor-Positive Breast Cancer (2012) (0)
How should nicotinamide be used clinically to overcome hypoxic cell radioresistance in human tumours (1993) (0)
2004 Intraperitoneal delivery of Chitosan/siRNA nanoparticles targeting TNF-a prevents radiation-induced fibrosis (2009) (0)
Risk of second primary cancer in hereditary and non-hereditary retinoblastoma: Results from a population based study with more than 40 years fOllow-up (1997) (0)
PD-0288: Compliance and toxicity of the hypoxic radiosensitizer nimorazole in patients with head and neck cancer (2014) (0)
OC-0516 Local control in HNSCC after introduction of geometric margins in DAHANCA radiotherapy guidelines (2021) (0)
Clinical trials are key to progress. (2003) (0)
Lack of prognostic significance of angiogenesis in non-small-cell lung carcinoma (1999) (0)
OC-045 Socioeconomic inequality in head and neck cancer survival- a population-based study from DAHANCA (2019) (0)
553Fractionation sensitivity of late radiation injury in the mouse rectum assessed by impedance planimetry (1996) (0)
Metabolic fate of 18F-FDG in mice bearing C3H mammary or squamous cell carcinoma (2002) (0)
OC-0449: Pattern of failure and disease control in patients treated for glottic cancer in Denmark 1971-2011 (2016) (0)
OC-0279 Hypoxic gene expression is a prognostic factor for survival in locally advanced SCC cervical cancer (2021) (0)
OC-0187: IAEA-HypoX. A randomized study of nimorazole with accelerated radiotherapy in HNSCC. Report of an incomplete trial (2015) (0)
Multifractionated HyperthermiaTreatmentof Malignantand Normal (1980) (0)
OC-0505 Distributed comparative patient selection in the DAHANCA35 RCT of protons vs photons for H&N cancer (2021) (0)
Influence of Time and Temperature on the Kinetics of Thermotolerance in LÃŒA2Cells in Vitro1 (2006) (0)
OC-0316: No prognostic impact of HPV on RT-outcome in advanced nonoropharynx cancer - analysis of 1606 DAHANCA patients (2014) (0)
188: Hpv Status and Effect on Radiosensitivity in Head and Neck Cancer Tumor Xenografts (2014) (0)
136 oral RISK FACTORS FOR SWALLOWING DYSFUNCTION AFTER RADIOTHERAPY IN THE DAHANCA 6 & 7 RANDOMIZED TRIAL (2011) (0)
A giant in radiotherapy has gone: Herman D. Suit 1926–2022 (2022) (0)
OC-0485: Genetic variants associated with radiation-induced morbidity in a head-and neck cancer cohort (2018) (0)
A Product of Lars-Gunnar Larsson (1994) (0)
PV-0519: The hypoxic radiosensitizer, nimorazole, in RT of HNSCC: pharmacokinetics, toxicity and compliance (2016) (0)
15: Oxygen ions achieve better tumour control probability in hypoxic tumours than carbon ions do (2014) (0)
Hyperfractionated or accelerated radiotherapy in head and neck cancer : a fractional benefit? Commentary : a meta-analysis. Commentary (2006) (0)
199 PREDICTIVE AND PROGNOSTIC MARKERS IN SERUM/PLASMA IN HEAD AND NECK CANCER PATIENTS (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jens Overgaard?

Jens Overgaard is affiliated with the following schools:

Aarhus University

Jens Overgaard's Academic­Influence.com Rankings